Search Results
197 items found for "chronic kidney disease"
- 📰 GPCR Weekly News, April 1 to 7, 2024
extracellular ATP/adenosine dynamics in zebrafish models of alcoholic and metabolic steatotic liver disease
- 📰 GPCR Weekly News, June 19 to 25, 2023
Specialized Pro-resolving Lipid Mediators and Resolution of Viral Diseases.
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
wakefulness LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease
- 📰 GPCR Buzz: August 5-11, 2024 | Top Highlights from DrGPCR University!
tyrosine kinase IGF1R and its associated GPCRs are co-regulated by the noncoding RNA NEAT1 in Alzheimer's disease
- 📰 GPCR Weekly News, May 1 to 7, 2023
G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders.
- 📰 GPCR Weekly News, December 4 to 10, 2023
neuroscience drugmaker Cerevel Therapeutics for $8.7 billion FDA approves two gene therapies for sickle cell disease
- 📰 GPCR Weekly News, August 21 to 27, 2023
Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
- 📰 GPCR Weekly News, August 14 to 20, 2023
Classified GPCR News from August 14 to 20, 2023 Adhesion GPCRs Amelioration of non-alcoholic fatty liver disease
- From DNA day to GPCR genomics
next-generation sequencing, have enabled the uncovering of associations between GPCR genetic variants and diseases
- Biased Agonism at the GLP-1 Receptor: A Pathway to Improved Therapeutic Outcomes
agonism at the GLP-1R represents a promising strategy for optimizing therapeutic outcomes in metabolic diseases
- 📰 GPCR Weekly News, August 28 to September 3, 2023
A case for (mutant) G protein-coupled receptors Reviews, GPCRs, and more RGS2 and female common diseases
- 📰 GPCR Weekly News, March 6 to 12, 2023
GPCRs in Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease
- 📰 GPCR Weekly News, February 5 to 11, 2024
G-protein coupled receptor-mediated vasocontraction in rat coronary arteries GPCRs involved in metabolic diseases
- 📰 GPCR Weekly News, January 8 to 14, 2024
more The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
- 📰 GPCR Weekly News, January 1 to 7, 2024
midgut development in Drosophila Structure, ligands, and roles of GPR126/ADGRG6 in the development and diseases
- 📰 GPCR Weekly News, April 10 to 16, 2023
Adhesion GPCRs Downstream signaling of the disease associated mutations on GPR56/ADGRG1.
- GPCR Buzz of the Week | Sep 23 - 29, 2024
and design of 5-HT6 antagonists through assessment of ANN-QSAR models in the context of Alzheimer's disease
- 📰 GPCR Weekly News, January 22 to 28, 2024
Financial Results Novartis Automates New Radioligand Therapy Production Plant Novartis’ Lutathera reduces disease
- 📰 GPCR Weekly News, March 13 to 19, 2023
and Immunology Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases
- 📰 GPCR Weekly News, December 18 to 31, 2023
optogenetically functionalized Drosophila dopamine receptors Targeting CB2R in astrocytes for Parkinson's disease
- 📰 GPCR Weekly News, May 13 to 19, 2024
GPCR-related genes analysis Reviews, GPCRs, and more GPR56, an Adhesion GPCR with Multiple Roles in Human Diseases
- 📰 GPCR Weekly News, February 19 to 25, 2024
A Perspective on Class C GPCR Based Genetically Encoded Biosensors Emergence of lumpy skin disease virus
- 📰 GPCR Weekly News, January 29 to February 4, 2024
Endocrinology, and Taste The role of P2Y6 receptor in the pathogenesis of cardiovascular and inflammatory diseases
- 📰 GPCR Weekly News
Ghrelin receptor signaling in health and disease: a biased view.
- 📰 GPCR Weekly News, May 6 to 12, 2024
of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases
- 📰 GPCR Weekly News, January 30 to February 5, 2023
The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards
- Decoding β-Arrestins: from Structure to function
the promise of unveiling novel insights into cellular signaling and its implications for health and disease
- Structural landscape of the Chemokine Receptor system
will pave the way for significant advancements in the development of therapeutics for a wide range of diseases